Provided are a class of alkynyl heteroaromatic ring-structured compounds, a pharmaceutically acceptable salt of same, a stereoisomer of same, an N-oxide of same, a solvate of same or a prodrug of same, a pharmaceutical composition having these compounds, and applications of these compounds or of the composition in the preparation of a medicament. The compounds are provided with improved anti-tumor activity.